Harbin Pharmaceutical Group Co.,Ltd.’s Net Profit Rose 25.9% in First Quarter of 2022

Harbin Pharmaceutical Group Co.,Ltd. (哈药集团股份有限公司) (600664.SH) reported a net profit of 109.9 million yuan in the first quarter of 2022, up 25.9% year-on-year.

Meanwhile, the company posted 3.3 billion yuan in revenue, up 11.9% year-on-year.

At the end of the reporting period, it had 12.8 billion yuan in total assets and 8.2 billion yuan in total liabilities, with a liability-to-asset ratio of 64.5%.